Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock

Abstract Background Angiotensin II is one of the vasopressors available for use in septic shock. However, its effects on the septic myocardium remain unclear. The aim of the study was to compare the effects of angiotensin II and norepinephrine on cardiac function and myocardial oxygen consumption, i...

Full description

Bibliographic Details
Main Authors: Bruno Garcia, Fuhong Su, Laurence Dewachter, Raphaël Favory, Amina Khaldi, Alexander Moiroux-Sahraoui, Filippo Annoni, Francisco Vasques-Nóvoa, Estela Rocha-Oliveira, Roberto Roncon-Albuquerque, Geraldine Hubesch, Hassane Njimi, Jean-Louis Vincent, Fabio S. Taccone, Jacques Creteur, Antoine Herpain
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Critical Care
Subjects:
Online Access:https://doi.org/10.1186/s13054-022-04161-3
_version_ 1798000705423802368
author Bruno Garcia
Fuhong Su
Laurence Dewachter
Raphaël Favory
Amina Khaldi
Alexander Moiroux-Sahraoui
Filippo Annoni
Francisco Vasques-Nóvoa
Estela Rocha-Oliveira
Roberto Roncon-Albuquerque
Geraldine Hubesch
Hassane Njimi
Jean-Louis Vincent
Fabio S. Taccone
Jacques Creteur
Antoine Herpain
author_facet Bruno Garcia
Fuhong Su
Laurence Dewachter
Raphaël Favory
Amina Khaldi
Alexander Moiroux-Sahraoui
Filippo Annoni
Francisco Vasques-Nóvoa
Estela Rocha-Oliveira
Roberto Roncon-Albuquerque
Geraldine Hubesch
Hassane Njimi
Jean-Louis Vincent
Fabio S. Taccone
Jacques Creteur
Antoine Herpain
author_sort Bruno Garcia
collection DOAJ
description Abstract Background Angiotensin II is one of the vasopressors available for use in septic shock. However, its effects on the septic myocardium remain unclear. The aim of the study was to compare the effects of angiotensin II and norepinephrine on cardiac function and myocardial oxygen consumption, inflammation and injury in experimental septic shock. Methods This randomized, open-label, controlled study was performed in 20 anesthetized and mechanically ventilated pigs. Septic shock was induced by fecal peritonitis in 16 animals, and four pigs served as shams. Resuscitation with fluids, antimicrobial therapy and abdominal drainage was initiated one hour after the onset of septic shock. Septic pigs were randomly allocated to receive one of the two drugs to maintain mean arterial pressure between 65 and 75 mmHg for 8 h. Results There were no differences in MAP, cardiac output, heart rate, fluid balance or tissue perfusion indices in the two treatment groups but myocardial oxygen consumption was greater in the norepinephrine-treated animals. Myocardial mRNA expression of interleukin-6, interleukin-6 receptor, interleukin-1 alpha, and interleukin-1 beta was higher in the norepinephrine than in the angiotensin II group. Conclusions In septic shock, angiotensin II administration is associated with a similar level of cardiovascular resuscitation and less myocardial oxygen consumption, and inflammation compared to norepinephrine.
first_indexed 2024-04-11T11:24:40Z
format Article
id doaj.art-39891891ee944cc9803ba90e223d342e
institution Directory Open Access Journal
issn 1364-8535
language English
last_indexed 2024-04-11T11:24:40Z
publishDate 2022-09-01
publisher BMC
record_format Article
series Critical Care
spelling doaj.art-39891891ee944cc9803ba90e223d342e2022-12-22T04:26:20ZengBMCCritical Care1364-85352022-09-0126111310.1186/s13054-022-04161-3Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shockBruno Garcia0Fuhong Su1Laurence Dewachter2Raphaël Favory3Amina Khaldi4Alexander Moiroux-Sahraoui5Filippo Annoni6Francisco Vasques-Nóvoa7Estela Rocha-Oliveira8Roberto Roncon-Albuquerque9Geraldine Hubesch10Hassane Njimi11Jean-Louis Vincent12Fabio S. Taccone13Jacques Creteur14Antoine Herpain15Experimental Laboratory of Intensive Care, Université Libre de BruxellesExperimental Laboratory of Intensive Care, Université Libre de BruxellesLaboratory of Physiology and Pharmacology, Université Libre de BruxellesDepartment of Intensive Care, Centre Hospitalier Universitaire de LilleExperimental Laboratory of Intensive Care, Université Libre de BruxellesExperimental Laboratory of Intensive Care, Université Libre de BruxellesExperimental Laboratory of Intensive Care, Université Libre de BruxellesCardiovascular R&D Center, Faculty of Medicine, University of PortoCardiovascular R&D Center, Faculty of Medicine, University of PortoCardiovascular R&D Center, Faculty of Medicine, University of PortoLaboratory of Physiology and Pharmacology, Université Libre de BruxellesDepartment of Intensive Care, Erasme University Hospital, Université Libre de BruxellesExperimental Laboratory of Intensive Care, Université Libre de BruxellesExperimental Laboratory of Intensive Care, Université Libre de BruxellesExperimental Laboratory of Intensive Care, Université Libre de BruxellesExperimental Laboratory of Intensive Care, Université Libre de BruxellesAbstract Background Angiotensin II is one of the vasopressors available for use in septic shock. However, its effects on the septic myocardium remain unclear. The aim of the study was to compare the effects of angiotensin II and norepinephrine on cardiac function and myocardial oxygen consumption, inflammation and injury in experimental septic shock. Methods This randomized, open-label, controlled study was performed in 20 anesthetized and mechanically ventilated pigs. Septic shock was induced by fecal peritonitis in 16 animals, and four pigs served as shams. Resuscitation with fluids, antimicrobial therapy and abdominal drainage was initiated one hour after the onset of septic shock. Septic pigs were randomly allocated to receive one of the two drugs to maintain mean arterial pressure between 65 and 75 mmHg for 8 h. Results There were no differences in MAP, cardiac output, heart rate, fluid balance or tissue perfusion indices in the two treatment groups but myocardial oxygen consumption was greater in the norepinephrine-treated animals. Myocardial mRNA expression of interleukin-6, interleukin-6 receptor, interleukin-1 alpha, and interleukin-1 beta was higher in the norepinephrine than in the angiotensin II group. Conclusions In septic shock, angiotensin II administration is associated with a similar level of cardiovascular resuscitation and less myocardial oxygen consumption, and inflammation compared to norepinephrine.https://doi.org/10.1186/s13054-022-04161-3Septic shockSeptic cardiomyopathyVasopressorsInflammationRenin-angiotensin system
spellingShingle Bruno Garcia
Fuhong Su
Laurence Dewachter
Raphaël Favory
Amina Khaldi
Alexander Moiroux-Sahraoui
Filippo Annoni
Francisco Vasques-Nóvoa
Estela Rocha-Oliveira
Roberto Roncon-Albuquerque
Geraldine Hubesch
Hassane Njimi
Jean-Louis Vincent
Fabio S. Taccone
Jacques Creteur
Antoine Herpain
Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock
Critical Care
Septic shock
Septic cardiomyopathy
Vasopressors
Inflammation
Renin-angiotensin system
title Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock
title_full Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock
title_fullStr Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock
title_full_unstemmed Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock
title_short Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock
title_sort myocardial effects of angiotensin ii compared to norepinephrine in an animal model of septic shock
topic Septic shock
Septic cardiomyopathy
Vasopressors
Inflammation
Renin-angiotensin system
url https://doi.org/10.1186/s13054-022-04161-3
work_keys_str_mv AT brunogarcia myocardialeffectsofangiotensiniicomparedtonorepinephrineinananimalmodelofsepticshock
AT fuhongsu myocardialeffectsofangiotensiniicomparedtonorepinephrineinananimalmodelofsepticshock
AT laurencedewachter myocardialeffectsofangiotensiniicomparedtonorepinephrineinananimalmodelofsepticshock
AT raphaelfavory myocardialeffectsofangiotensiniicomparedtonorepinephrineinananimalmodelofsepticshock
AT aminakhaldi myocardialeffectsofangiotensiniicomparedtonorepinephrineinananimalmodelofsepticshock
AT alexandermoirouxsahraoui myocardialeffectsofangiotensiniicomparedtonorepinephrineinananimalmodelofsepticshock
AT filippoannoni myocardialeffectsofangiotensiniicomparedtonorepinephrineinananimalmodelofsepticshock
AT franciscovasquesnovoa myocardialeffectsofangiotensiniicomparedtonorepinephrineinananimalmodelofsepticshock
AT estelarochaoliveira myocardialeffectsofangiotensiniicomparedtonorepinephrineinananimalmodelofsepticshock
AT robertoronconalbuquerque myocardialeffectsofangiotensiniicomparedtonorepinephrineinananimalmodelofsepticshock
AT geraldinehubesch myocardialeffectsofangiotensiniicomparedtonorepinephrineinananimalmodelofsepticshock
AT hassanenjimi myocardialeffectsofangiotensiniicomparedtonorepinephrineinananimalmodelofsepticshock
AT jeanlouisvincent myocardialeffectsofangiotensiniicomparedtonorepinephrineinananimalmodelofsepticshock
AT fabiostaccone myocardialeffectsofangiotensiniicomparedtonorepinephrineinananimalmodelofsepticshock
AT jacquescreteur myocardialeffectsofangiotensiniicomparedtonorepinephrineinananimalmodelofsepticshock
AT antoineherpain myocardialeffectsofangiotensiniicomparedtonorepinephrineinananimalmodelofsepticshock